| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,620 |
6,387 |
$2.98M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,346 |
8,114 |
$2.48M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,655 |
9,900 |
$2.38M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,464 |
2,034 |
$223K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
239 |
162 |
$190K |
| 80053 |
Comprehensive metabolic panel |
2,379 |
2,088 |
$60K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,661 |
3,140 |
$53K |
| 71046 |
Radiologic examination, chest; 2 views |
707 |
657 |
$40K |
| 36415 |
Collection of venous blood by venipuncture |
8,757 |
7,347 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,748 |
1,681 |
$34K |
| 87428 |
|
555 |
533 |
$32K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
282 |
268 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
446 |
383 |
$30K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
247 |
216 |
$29K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
76 |
69 |
$26K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
230 |
90 |
$24K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
109 |
91 |
$24K |
| 80050 |
General health panel |
406 |
370 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
718 |
680 |
$19K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
214 |
186 |
$17K |
| 87070 |
|
1,290 |
1,237 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
214 |
202 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
73 |
66 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
186 |
173 |
$8K |
| 81015 |
|
1,870 |
1,707 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
37 |
29 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
12 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
340 |
315 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
445 |
410 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
648 |
423 |
$3K |
| 87807 |
|
144 |
139 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
43 |
41 |
$3K |
| 81003 |
|
767 |
693 |
$2K |
| 81001 |
|
240 |
222 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
150 |
91 |
$2K |
| 84484 |
|
93 |
79 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
43 |
41 |
$2K |
| 87186 |
|
121 |
115 |
$2K |
| 81025 |
|
114 |
108 |
$1K |
| 80061 |
Lipid panel |
46 |
36 |
$1K |
| 74019 |
|
12 |
12 |
$953.80 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
78 |
72 |
$921.28 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
57 |
51 |
$730.34 |
| 87088 |
|
55 |
55 |
$639.33 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
12 |
$626.40 |
| 90686 |
|
92 |
88 |
$545.27 |
| 83690 |
|
46 |
40 |
$367.52 |
| 86140 |
|
29 |
25 |
$235.24 |
| 90662 |
|
13 |
13 |
$230.40 |
| 85610 |
|
13 |
12 |
$168.73 |
| 83605 |
|
16 |
12 |
$71.75 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$12.57 |
| A9270 |
Non-covered item or service |
14 |
13 |
$0.00 |